Join
Live feed
·
PRReleasevia Quantisnow
Eloxx Pharmaceuticals Inc. logo

Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
ELOX· Eloxx Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELOX (Eloxx Pharmaceuticals Inc.) and more on Quantisnow.